Targeted Sequencing of an Epidemiologically Low Risk patient defines Fibroblast Growth Factor Family Aberrations as a putative driver of Head and Neck Squamous Cell Carcinoma

BACKGROUND: Targeted sequencing of epidemiologically low risk (ELR) HNSCC patients could help identify novel drivers or lost suppressors leading to precision medicine protocols and improved survival rates. METHODS: An ELR-HNSCC patient was selected for targeted sequencing. We then assessed next gene...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Head Neck
Hlavní autoři: Tillman, Brittny N., Yanik, Megan, Birkeland, Andrew C., Liu, Chia-Jen, Hovelson, Daniel H., Cani, Andi K., Palanisamy, Nallasivam, Carskadon, Shannon, Carey, Thomas E., Bradford, Carol R., Tomlins, Scott A., McHugh, Jonathan B., Spector, Matthew E., Brenner, J. Chad
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4844767/
https://ncbi.nlm.nih.gov/pubmed/26849095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.24292
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky